Sanofi's BD chief heads to Owkin as CBO; Roche re­lies on its bench for Thomas Schi­neck­er’s di­ag­nos­tics re­place­ment

Up un­til re­cent­ly, Al­ban de La Sablière was Sanofi’s chief deal­mak­er, re­port­ing di­rect­ly to CEO Paul Hud­son with­out of­fi­cial­ly be­ing a C-suite ex­ec­u­tive.
That’s now …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER